AVISTA PHARMA (NOW CAMBREX)
SUCCESS BEYOND SCIENCE
Turning scientists into talent to help a pharmaceutical contract development and manufacturing organization (CDMO) formulate distinction in a crowded category.
SNAPSHOT
Avista Pharma Solutions, an investor-backed CDMO, came to us with a simple request: “Make us look bigger.” So we turned their standout scientists into talent.
CHALLENGE
Help this innovative, growth-minded CDMO grow brand value to meet an aggressive business-growth target, which included a three year acquisition exit strategy.
APPROACH
+ Research & Strategic Positioning
+ Messaging Platform Development
+ Event Strategy & Booth Redesign
+ Thought-leadership Campaign
+ Brand Awareness Campaign
+ Employee Engagement Campaign
RESULTS
Internal teams rallied around the celebration of Avista’s scientists as spokespeople, and our campaign increased its share of voice in the market by nearly 50 and accelerated their exit.
Agency Credit: BAERING
In 2018, Avista was acquired by Cambrex for approximately $252M — a significant increase from previous years’ valuations, and 2x faster than goal.
THE CREATIVE
